PDS Biotechnology Corporation (PDSB)
Nasdaq: PDSB · Pharmaceutical Preparations · Princeton, NJ · filing with the SEC since 2009
Who runs PDS Biotechnology Corporation
Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filedChief executive, as filed
Bedu-Addo Frank
President/CEO. First filing Mar 2019, latest Mar 3, 2026, 0 filings in all.
Officers reporting now
7
of 17 people with a filing in the last fifteen months
Directors reporting now
10
46 people on the record since 2015
Officerssales are open-market, Oct 21, 2025 to Oct 21, 2026
| Name | Title as filed | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Trochimiuk Janetta | Principal Accounting Officer | Mar 2020 | Sep 18, 2026 | none |
| Bedu-Addo Frank | President/CEO | Mar 2019 | Mar 3, 2026 | none |
| Boesgaard Lars | Chief Financial Officer | Dec 2023 | Mar 3, 2026 | none |
| Toutain Stephan | Chief Operating Officer | May 2024 | Mar 3, 2026 | none |
| Conn Gregory | Chief Scientific Officer | Mar 2019 | Mar 3, 2026 | none |
| Shepard Kirk V. | Chief Medical Officer | Jan 2024 | Mar 3, 2026 | none |
| Brown Spencer D. | Senior VP, General Counsel | Jun 2022 | Mar 3, 2026 | none |
Directorssales are open-market, Oct 21, 2025 to Oct 21, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Dawson John Andrew | director | Oct 2026 | Oct 21, 2026 | none |
| Ramsdell Deborah | director | Oct 2026 | Oct 20, 2026 | none |
| Wendel Bruce | director | Oct 2026 | Oct 20, 2026 | none |
| Banaag Arnold James | director | Sep 2026 | Sep 21, 2026 | none |
| Soon-Shiong Patrick | director | Sep 2026 | Sep 21, 2026 | none |
| Ali-Jackson Kamil | director | Feb 2020 | Mar 3, 2026 | none |
| Brawley Otis W | director | Nov 2020 | Mar 3, 2026 | none |
| Freitag Gregory Gene | director | Mar 2019 | Mar 3, 2026 | none |
| Glover Steve C | director | Apr 2019 | Mar 3, 2026 | none |
| Iliev Ilian | director | Apr 2020 | Mar 3, 2026 | none |
Owners of more than 10% of a classsales are open-market, Oct 21, 2025 to Oct 21, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Nant Capital, LLC | 10% owner | Sep 2026 | Sep 21, 2026 | none |
Earlier names on the record29, newest filing first
Sykes Richard · director · last filing Jun 2024Hill Matthew C · officer · last filing Jan 2023Wood Lauren · officer · last filing Jan 2023Bloomquist Delyle W · director · last filing Jun 2021Van Voorhees Seth · officer · last filing Jun 2021King Michael N. · officer · last filing Dec 2020Saik Andrew · officer · last filing Feb 2020Loughlin James J · director · last filing Jul 2019Leuthner Brian A · officer · last filing Mar 2019Macdonald R. Loch · officer · last filing Mar 2019Middlekauff W Bradford · officer · last filing Mar 2019Barer Sol J · director · last filing Mar 2019Blech Isaac · director · last filing Mar 2019Crane Rosemary A · director · last filing Mar 2019Ratcliffe Liam · director · last filing Mar 2019Spiegel Robert J. · director · last filing Mar 2019Wyant Alyssa · officer · last filing Jan 2019Faleck Herbert J · officer · last filing Dec 2018Marchio Albert N II · officer · last filing Dec 2018Conti Kurt G · director · last filing Mar 2018Brennan Daniel · officer · last filing Mar 2018Healy James · director · last filing Jun 2017Yaman Alpaslan · officer · last filing Mar 2017Einhorn Andrew J. · officer · last filing Mar 2017New Leaf Venture Associates III, L.P. · director · last filing Jun 2016New Leaf Venture Management III, L.L.C. · director · last filing Jun 2016New Leaf Venture Partners, L.L.C. · director · last filing Jun 2016New Leaf Ventures III, L.P. · director · last filing Jun 2016Vaish Renu · officer · last filing Jun 2016
A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.